Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Amarin Corporation plc: Amarin Applauds HealthyWomen's Citizen's Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event | 52 | GlobeNewswire (Europe) | DUBLIN, Ireland and BRIDGEWATER, N.J., April 24, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced its support for a petition filed with the U.S. Food and Drug Administration... ► Artikel lesen | |
22.04. | AMARIN CORP PLC - 8-K, Current Report | 1 | SEC Filings | ||
22.04. | Amarin Corporation plc: Amarin Announces Results of Annual General Meeting of Shareholders | 102 | GlobeNewswire (Europe) | DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced shareholder approval of all proposed resolutions specified at its 2024... ► Artikel lesen | |
08.04. | Amarin Corporation plc: Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 | 6 | GlobeNewswire (USA) | ||
06.04. | Amarin Corporation plc: New REDUCE-IT Analyses Show VASCEPA/VAZKEPA (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups | 574 | GlobeNewswire (Europe) | -- Findings Presented on VASCEPA/VAZKEPA Utility in REDUCE-IT Patient Subgroups by Baseline High/Low Lp(a), LDL-C Levels -- -- Lp(a) Results Published Simultaneously in the Journal of the American... ► Artikel lesen | |
04.04. | Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe | 8 | Zacks | ||
03.04. | Why Amarin Stock Was Rocketing Higher on Wednesday | 9 | The Motley Fool | ||
03.04. | Amarin: IP Protection For VAZKEPA In Europe Now Extended Into 2039 | 5 | RTTNews | ||
03.04. | Amarin Corporation plc: Amarin Provides Update on VAZKEPA (Icosapent Ethyl) Intellectual Property Portfolio in Europe | 104 | GlobeNewswire (Europe) | DUBLIN, Ireland and BRIDGEWATER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company received a Decision to Grant from the European Patent... ► Artikel lesen | |
03.04. | AMARIN CORP PLC - 8-K, Current Report | 3 | SEC Filings | ||
29.03. | Teva, following Hikma complaint, alleges Amarin 'locked up' Vascepa ingredient to block generics | 33 | FiercePharma | ||
25.03. | Amarin Corporation plc: Research Evaluating Benefits of VASCEPA/VAZKEPA (icosapent ethyl) to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo | 128 | GlobeNewswire (Europe) | -- Subgroup Analyses from REDUCE-IT® and Mechanistic Data on Icosapent Ethyl(IPE)/Eicosapentaenoic Acid (EPA) Featured at the Meeting -- DUBLIN, Ireland and BRIDGEWATER, N.J., March 25, 2024 (GLOBE... ► Artikel lesen | |
06.03. | Sirivadhanabhakdi Family Tenders for Entire Business of 'Amarin Corporations' | 1 | Kaohoon International | ||
01.03. | Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates | 31 | Zacks | ||
29.02. | Why Is Amarin Stock Trading Lower After Q4 Earnings? | 29 | Benzinga.com | ||
29.02. | Amarin Corporation PLC reports results for the quarter ended in December - Earnings Summary | 11 | Reuters | ||
29.02. | Amarin Non-GAAP EPS of $0.00 beats by $0.03, revenue of $74.71M beats by $3.61M | 25 | Seeking Alpha | ||
29.02. | AMARIN CORP PLC - 8-K, Current Report | 1 | SEC Filings | ||
29.02. | AMARIN CORP PLC - 10-K, Annual Report | 5 | SEC Filings | ||
29.02. | Amarin Corporation plc: Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | 277 | GlobeNewswire (Europe) | -- Company Delivers Total Revenues of $75 Million in the Fourth Quarter and $306 Million for the Full-Year 2023 ---- Reaffirms Year-End 2023 Cash Position of $321 Million and Full-Year Positive Cash... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 428 |
NVIDIA | 247 |
DEUTSCHE BANK | 246 |
BAYER | 211 |
TESLA | 189 |
RHEINMETALL | 182 |
NEL | 178 |
BYD | 169 |
TUI | 160 |
SUPER MICRO COMPUTER | 152 |
BASF | 118 |
MERCEDES-BENZ | 113 |
AMAZON | 104 |
RWE | 102 |
VARTA | 102 |
MICROSOFT | 96 |
THYSSENKRUPP | 96 |
PLUG POWER | 94 |
AIXTRON SE | 93 |
VOLKSWAGEN | 92 |
XIAOMI | 92 |
COMMERZBANK | 89 |
DEUTSCHE LUFTHANSA | 87 |
ALPHABET | 81 |
DELIVERY HERO | 80 |